{
    "2021-04-19": [
        [
            {
                "time": "2020-01-01",
                "original_text": "智飞生物业绩持续高速增长",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "智飞生物一季度净利润同比增长82%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "一季度",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "智飞生物(300122.SZ)2020年度净利润升39.51%至33.01亿元拟10派5元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2020年度",
                        "净利润",
                        "分红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "智飞生物(300122.SZ)一季度净利润升81.69%至9.38亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "一季度",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "智飞生物(300122.SZ)拟向金融机构申请不超150亿元授信额度",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "授信额度",
                        "金融机构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "智飞生物(300122.SZ)2020年度归母净利同比增39.5%至33亿元 拟10派5元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2020年度",
                        "归母净利",
                        "分红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "智飞生物(300122.SZ)第一季度归母净利润同比增长81.7%至9.38亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "第一季度",
                        "归母净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "智飞生物：一季度净利润同比增长81.69%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "一季度",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "智飞生物：2020年净利润同比增长39.51%",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2020年",
                        "净利润",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "上交所、中证指数公司发布中证红利质量指数等3条指数",
                "features": {
                    "keywords": [
                        "上交所",
                        "中证指数",
                        "红利质量指数"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "长春高新、复星医药、智飞生物集体大涨提振疫苗板块",
                "features": {
                    "keywords": [
                        "长春高新",
                        "复星医药",
                        "智飞生物",
                        "疫苗板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "粤开证券---医药行业周报：网售处方药全面放开，第五批带量采购箭在弦上【行业研究】",
                "features": {
                    "keywords": [
                        "医药行业",
                        "网售处方药",
                        "带量采购"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "机构抱团股大反攻！聪明资金埋伏一季报个股名单曝光",
                "features": {
                    "keywords": [
                        "机构抱团",
                        "一季报",
                        "个股名单"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "华为造车引爆A股：千亿巨头涨停，外资狂买138亿",
                "features": {
                    "keywords": [
                        "华为",
                        "造车",
                        "A股",
                        "外资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "汽车"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-01",
                "original_text": "东吴证券---医药生物行业：第五批带量采购对恒瑞医药影响有限，仍坚定看好【行业研究】",
                "features": {
                    "keywords": [
                        "医药生物",
                        "带量采购",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}